227 related articles for article (PubMed ID: 18467434)
1. The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation.
Teng J; Wang ZY; Prossnitz ER; Bjorling DE
Endocrinology; 2008 Aug; 149(8):4024-34. PubMed ID: 18467434
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage.
Hsieh YC; Yu HP; Frink M; Suzuki T; Choudhry MA; Schwacha MG; Chaudry IH
Am J Pathol; 2007 Apr; 170(4):1210-8. PubMed ID: 17392161
[TBL] [Abstract][Full Text] [Related]
4. The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the neuroprotective action of daidzein.
Kajta M; Rzemieniec J; Litwa E; Lason W; Lenartowicz M; Krzeptowski W; Wojtowicz AK
Neuroscience; 2013 May; 238():345-60. PubMed ID: 23419549
[TBL] [Abstract][Full Text] [Related]
5. Involvement of G protein-coupled receptor 30 (GPR30) in rapid action of estrogen in primate LHRH neurons.
Noel SD; Keen KL; Baumann DI; Filardo EJ; Terasawa E
Mol Endocrinol; 2009 Mar; 23(3):349-59. PubMed ID: 19131510
[TBL] [Abstract][Full Text] [Related]
6. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.
Sirianni R; Chimento A; Ruggiero C; De Luca A; Lappano R; Andò S; Maggiolini M; Pezzi V
Endocrinology; 2008 Oct; 149(10):5043-51. PubMed ID: 18566133
[TBL] [Abstract][Full Text] [Related]
7. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S
J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535
[TBL] [Abstract][Full Text] [Related]
8. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.
Kang L; Zhang X; Xie Y; Tu Y; Wang D; Liu Z; Wang ZY
Mol Endocrinol; 2010 Apr; 24(4):709-21. PubMed ID: 20197310
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.
Girgert R; Emons G; Gründker C
BMC Cancer; 2014 Dec; 14():935. PubMed ID: 25496649
[TBL] [Abstract][Full Text] [Related]
10. Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway.
Zhang Y; Wei F; Zhang J; Hao L; Jiang J; Dang L; Mei D; Fan S; Yu Y; Jiang L
Arch Biochem Biophys; 2017 Nov; 633():29-39. PubMed ID: 28882636
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional roles of estrogen receptor GPR30 in human intervertebral disc.
Wei A; Shen B; Williams LA; Bhargav D; Yan F; Chong BH; Diwan AD
J Steroid Biochem Mol Biol; 2016 Apr; 158():46-55. PubMed ID: 26815911
[TBL] [Abstract][Full Text] [Related]
12. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.
Vivacqua A; Bonofiglio D; Albanito L; Madeo A; Rago V; Carpino A; Musti AM; Picard D; Andò S; Maggiolini M
Mol Pharmacol; 2006 Oct; 70(4):1414-23. PubMed ID: 16835357
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
14. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
15. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alpha.
Chimento A; Sirianni R; Delalande C; Silandre D; Bois C; Andò S; Maggiolini M; Carreau S; Pezzi V
Mol Cell Endocrinol; 2010 May; 320(1-2):136-44. PubMed ID: 20132863
[TBL] [Abstract][Full Text] [Related]
17. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
18. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled receptor 30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary.
Wang C; Prossnitz ER; Roy SK
Endocrinology; 2008 Sep; 149(9):4452-61. PubMed ID: 18499747
[TBL] [Abstract][Full Text] [Related]
20. Ligand-Independent G Protein-Coupled Estrogen Receptor/G Protein-Coupled Receptor 30 Activity: Lack of Receptor-Dependent Effects of G-1 and 17
Tutzauer J; Gonzalez de Valdivia E; Swärd K; Alexandrakis Eilard I; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
Mol Pharmacol; 2021 Sep; 100(3):271-282. PubMed ID: 34330822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
